Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study

Creative Commons License

TaŞdemİr M., Canpolat N., Yildiz N., ÖzÇelİk G., Benzer M., Saygili S. K., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.4, ss.1781-1790, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 51 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.3906/sag-2012-297
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1781-1790
  • Anahtar Kelimeler: Frequently relapsing nephrotic syndrome, immunosuppressive agents, steroid-dependent nephrotic syndrome, steroid-resistant nephrotic syndrome, remission, CHILDHOOD-ONSET, FOLLOW-UP, CYCLOSPORINE
  • Marmara Üniversitesi Adresli: Evet

Özet

Background/aim: This study aimed to evaluate the efficacy of rituximab in children with difficult-to-treat nephrotic syndrome, considering the type of disease (steroid-sensitive or -resistant) and the dosing regimen.